{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:38:40Z","timestamp":1790797120045,"version":"4.1.0"},"reference-count":179,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2017.00086","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T22:51:06Z","timestamp":1487890266000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":301,"title":["Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review"],"prefix":"10.3389","volume":"8","author":[{"given":"Nicolas","family":"Kerckhove","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Collin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakahl\u00e9","family":"Cond\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Chaleteix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Pezet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Balayssac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,2,24]]},"reference":[{"issue":"45","key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s12990-015-0048-8","article-title":"KCNQ channels in nociceptive cold-sensing trigeminal ganglion neurons as therapeutic targets for treating orofacial cold hyperalgesia.","volume":"11","author":"Abd-Elsayed","year":"2015","journal-title":"Mol. Pain"},{"key":"B2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000362668","article-title":"Incidence of cold-induced peripheral neuropathy and dose modification of adjuvant oxaliplatin-based chemotherapy for patients with colorectal cancer.","volume":"87","author":"Altaf","year":"2014","journal-title":"Oncology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1016\/s1074-5521(99)89002-4","article-title":"How Taxol stabilises microtubule structure.","volume":"6","author":"Amos","year":"1999","journal-title":"Chem. Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","article-title":"Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.","volume":"27","author":"Andr\u00e9","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1158\/1078-0432.CCR-10-1950","article-title":"Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events.","volume":"17","author":"Arastu-Kapur","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.critrevonc.2011.04.012","article-title":"Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.","volume":"82","author":"Argyriou","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1002\/cncr.28234","article-title":"Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study.","volume":"119","author":"Argyriou","year":"2013","journal-title":"Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s00204-014-1316-5","article-title":"Bortezomib-induced peripheral neurotoxicity: an update.","volume":"88","author":"Argyriou","year":"2014","journal-title":"Arch. Toxicol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.pain.2009.03.024","article-title":"Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study.","volume":"144","author":"Attal","year":"2009","journal-title":"Pain"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/cncr.22921","article-title":"Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature.","volume":"110","author":"Badros","year":"2007","journal-title":"Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1517\/14740338.2011.543417","article-title":"Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence.","volume":"10","author":"Balayssac","year":"2011","journal-title":"Expert Opin. Drug Saf."},{"key":"B12","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1158\/1078-0432.CCR-12-1590","article-title":"A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.","volume":"18","author":"Baldwin","year":"2012","journal-title":"Am. Assoc. Cancer Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10549-016-3939-0","article-title":"Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk.","volume":"159","author":"Bao","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"key":"B14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.pain.2011.11.019","article-title":"Paclitaxel therapy potentiates cold hyperalgesia in streptozotocin-induced diabetic rats through enhanced mitochondrial reactive oxygen species production and TRPA1 sensitization.","volume":"153","author":"Barri\u00e8re","year":"2012","journal-title":"Pain"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuro.2013.12.002","article-title":"The neuroprotective effect of tropisetron on vincristine-induced neurotoxicity.","volume":"41","author":"Barzegar-Fallah","year":"2014","journal-title":"Neurotoxicology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.12788\/jcso.0086","article-title":"Chemotherapy-induced peripheral neuropathy and impact on quality of life 6 months after treatment with chemotherapy.","volume":"12","author":"Beijers","year":"2014","journal-title":"J. Community Support. Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s00520-014-2242-z","article-title":"A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration.","volume":"22","author":"Beijers","year":"2014","journal-title":"Support. Care Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s00520-015-3032-y","article-title":"Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice.","volume":"24","author":"Beijers","year":"2016","journal-title":"Support. Care Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00280-012-2047-z","article-title":"Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine.","volume":"71","author":"Boyette-Davis","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","article-title":"Colorectal cancer.","volume":"383","author":"Brenner","year":"2014","journal-title":"Lancet Lond. Engl."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1470-2045(10)70206-0","article-title":"Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65\/GMMG-HD4 trial.","volume":"11","author":"Broyl","year":"2010","journal-title":"Lancet Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1093\/jnci\/djp413","article-title":"Observational study of prevalence of long-term raynaud-like phenomena and neurological side effects in testicular cancer survivors.","volume":"101","author":"Brydoy","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"B23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.expneurol.2010.09.004","article-title":"Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies.","volume":"226","author":"Carozzi","year":"2010","journal-title":"Exp. Neurol."},{"issue":"e72995","key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072995","article-title":"Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse.","volume":"8","author":"Carozzi","year":"2013","journal-title":"PLoS ONE"},{"key":"B25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jpain.2006.09.014","article-title":"Quantitative sensory findings in patients with bortezomib-induced pain.","volume":"8","author":"Cata","year":"2007","journal-title":"J. Pain"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1212\/WNL.62.12.2291","article-title":"Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study.","volume":"62","author":"Cavaletti","year":"2004","journal-title":"Neurology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3109\/10428194.2010.483303","article-title":"Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies.","volume":"51","author":"Cavaletti","year":"2010","journal-title":"Leuk. Lymphoma"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/S0959-8049(02)00229-0","article-title":"Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity.","volume":"1990","author":"Cavaletti","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1212\/01.WNL.0000043691.53710.53","article-title":"Toxic neuropathy in patients with pre-existing neuropathy.","volume":"60","author":"Chaudhry","year":"2003","journal-title":"Neurology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1529-8027.2008.00193.x","article-title":"Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy.","volume":"13","author":"Chaudhry","year":"2008","journal-title":"J. Peripher. Nerv. Syst."},{"key":"B31","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ana.410350310","article-title":"Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies.","volume":"35","author":"Chaudhry","year":"1994","journal-title":"Ann. Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00228-013-1596-3","article-title":"Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXR\u03b1 and HNF4\u03b1) on docetaxel disposition in Chinese nasopharyngeal cancer patients.","volume":"70","author":"Chew","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/annonc\/mdt546","article-title":"Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study.","volume":"25","author":"Custodio","year":"2014","journal-title":"Ann. Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1158\/1078-0432.CCR-12-3786","article-title":"CYP3A4\u221722 genotype and systemic exposure affect paclitaxel-induced neurotoxicity.","volume":"19","author":"de Graan","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.critrevonc.2015.04.011","article-title":"Taxane induced neuropathy in patients affected by breast cancer: literature review.","volume":"96","author":"De Iuliis","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/emmm.201100134","article-title":"Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors.","volume":"3","author":"Descoeur","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jpain.2011.11.009","article-title":"Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin.","volume":"13","author":"Di Cesare Mannelli","year":"2012","journal-title":"J. Pain"},{"key":"B38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.freeradbiomed.2016.01.023","article-title":"Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: possible aid in chemotherapy induced neuropathy.","volume":"93","author":"Di Cesare Mannelli","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00280-016-2976-z","article-title":"Platinum-based drugs: past, present and future.","volume":"77","author":"Dilruba","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1600-0609.2010.01533.x","article-title":"Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study.","volume":"86","author":"Dimopoulos","year":"2011","journal-title":"Eur. J. Haematol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/jama.2015.0894","article-title":"Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.","volume":"313","author":"Diouf","year":"2015","journal-title":"JAMA"},{"key":"B42","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pain.2004.01.021","article-title":"Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients.","volume":"109","author":"Dougherty","year":"2004","journal-title":"Pain"},{"key":"B43","doi-asserted-by":"publisher","first-page":"6149","DOI":"10.1523\/JNEUROSCI.6343-11.2012","article-title":"Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic pain.","volume":"32","author":"Doyle","year":"2012","journal-title":"J. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"9451","DOI":"10.1523\/JNEUROSCI.0523-07.2007","article-title":"Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy.","volume":"27","author":"Dzagnidze","year":"2007","journal-title":"J. Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/13577149878055","article-title":"Long-term neurotoxicity of chemotherapy in adolescents and young adults treated for bone and soft tissue sarcomas.","volume":"2","author":"Earl","year":"1998","journal-title":"Sarcoma"},{"key":"B46","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ejca.2014.11.024","article-title":"Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors.","volume":"51","author":"Eckhoff","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"B47","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/pbc.22845","article-title":"Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia.","volume":"56","author":"Egbelakin","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.ejca.2009.01.006","article-title":"Long-term morbidity of adjuvant whole abdominal radiotherapy (WART) or chemotherapy for early stage ovarian cancer.","volume":"45","author":"Engelen","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1523\/JNEUROSCI.3127-04.2005","article-title":"Activation of nuclear factor-kappaB via endogenous tumor necrosis factor alpha regulates survival of axotomized adult sensory neurons.","volume":"25","author":"Fernyhough","year":"2005","journal-title":"J. Neurosci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.ctrv.2015.10.010","article-title":"Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: a systematic review.","volume":"41","author":"Frederiks","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/S0959-8049(03)00489-1","article-title":"Why and how to study the fate of cancer survivors: observations from the clinic and the research laboratory.","volume":"39","author":"Ganz","year":"2003","journal-title":"Eur. J. Cancer"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2337","article-title":"Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array.","author":"Garc\u00eda-Sanz","year":"2016","journal-title":"Hematol. Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neulet.2009.04.029","article-title":"Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice.","volume":"458","author":"Gauchan","year":"2009","journal-title":"Neurosci. Lett."},{"key":"B54","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1212\/01.WNL.0000049462.03800.B1","article-title":"Thalidomide-induced neuropathy: a ganglionopathy?","volume":"60","author":"Giannini","year":"2003","journal-title":"Neurology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuro.2011.10.010","article-title":"Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy.","volume":"33","author":"Gilardini","year":"2012","journal-title":"Neurotoxicology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/pbc.26204","article-title":"Short-term recovery of chemotherapy-induced peripheral neuropathy after treatment for pediatric non-CNS cancer.","volume":"64","author":"Gilchrist","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"B57","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1365-2141.2005.05914.x","article-title":"A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma.","volume":"132","author":"Glasmacher","year":"2006","journal-title":"Br. J. Haematol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1002\/cncr.24981","article-title":"Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancer.","volume":"116","author":"Glendenning","year":"2010","journal-title":"Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1468-1331.2007.01842.x","article-title":"Vincristine-induced acute neurotoxicity versus Guillain-Barr\u00e9 syndrome: a diagnostic dilemma.","volume":"14","author":"Gonz\u00e1lez P\u00e9rez","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuropharm.2013.08.016","article-title":"The paradox of paclitaxel neurotoxicity: mechanisms and unanswered questions.","volume":"76(Pt A)","author":"Gornstein","year":"2014","journal-title":"Neuropharmacology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neuro.2010.09.006","article-title":"Vasodilatation in the rat dorsal hindpaw induced by activation of sensory neurons is reduced by paclitaxel.","volume":"32","author":"Gracias","year":"2011","journal-title":"Neurotoxicology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/(SICI)1097-0142(19960401)77:71356::AID-CNCR203.0.CO;2-#","article-title":"Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A.","volume":"77","author":"Graf","year":"1996","journal-title":"Cancer"},{"key":"B63","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1742-7843.2008.00351.x","article-title":"Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer.","volume":"104","author":"Gr\u00e9en","year":"2009","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1002\/1097-0142(19940515)73:102515::AID-CNCR28207310113.0.CO;2-G","article-title":"Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomas.","volume":"73","author":"Haim","year":"1994","journal-title":"Cancer"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.ejca.2014.06.007","article-title":"Comparison of patient reported quality of life and impact of treatment side effects experienced with a taxane-containing regimen and standard anthracycline based chemotherapy for early breast cancer: 6 year results from the UK TACT trial (CRUK\/01\/001).","volume":"50","author":"Hall","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"207","key":"B66","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5977.207","article-title":"Vincristine-induced autonomic neuropathy.","volume":"3","author":"Hancock","year":"1975","journal-title":"Br. Med. J."},{"key":"B67","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.pain.2013.02.023","article-title":"Effect of paclitaxel on transient receptor potential vanilloid 1 in rat dorsal root ganglion.","volume":"154","author":"Hara","year":"2013","journal-title":"Pain"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.","volume":"32","author":"Hershman","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10549-010-1278-0","article-title":"Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy.","volume":"125","author":"Hershman","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/annonc\/mdt018","article-title":"CYP2C8\u22173 increases risk of neuropathy in breast cancer patients treated with paclitaxel.","volume":"24","author":"Hertz","year":"2013","journal-title":"Ann. Oncol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/1097-0142(19890815)64:4801::AID-CNCR28206404063.0.CO;2-E","article-title":"Vincristine treatment of acute lymphoblastic leukemia induces transient autonomic cardioneuropathy.","volume":"64","author":"Hirvonen","year":"1989","journal-title":"Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2147\/CMAR.S40601","article-title":"Presentation and management of docetaxel-related adverse effects in patients with breast cancer.","volume":"6","author":"Ho","year":"2014","journal-title":"Cancer Manag. Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/ilar\/ilt053","article-title":"Rodent models of chemotherapy-induced peripheral neuropathy.","volume":"54","author":"H\u00f6ke","year":"2014","journal-title":"ILAR J."},{"key":"B74","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3747\/co.21.1984","article-title":"The influence of chemotherapy-induced neurotoxicity on psychological distress and sleep disturbance in cancer patients.","volume":"21","author":"Hong","year":"2014","journal-title":"Curr. Oncol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/cm.20283","article-title":"Live-cell analysis of mitotic spindle formation in taxol-treated cells.","volume":"65","author":"Hornick","year":"2008","journal-title":"Cell Motil. Cytoskeleton"},{"key":"B76","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.tins.2012.03.007","article-title":"p75 neurotrophin receptor signaling in nervous system injury and degeneration: paradox and opportunity.","volume":"35","author":"Ib\u00e1\u00f1ez","year":"2012","journal-title":"Trends Neurosci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuint.2009.09.004","article-title":"Piccolo knockdown-induced impairments of spatial learning and long-term potentiation in the hippocampal CA1 region.","volume":"56","author":"Ibi","year":"2010","journal-title":"Neurochem. Int."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tox.2011.10.019","article-title":"Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy.","volume":"291","author":"Jaggi","year":"2012","journal-title":"Toxicology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1177\/0883073813491829","article-title":"Vincristine-induced neuropathy in childhood ALL (acute lymphoblastic leukemia) survivors: prevalence and electrophysiological characteristics.","volume":"29","author":"Jain","year":"2014","journal-title":"J. Child Neurol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1038\/sj.bjc.6601012","article-title":"Paclitaxel induces nucleolar enlargement in dorsal root ganglion neurons in vivo reducing oxaliplatin toxicity.","volume":"88","author":"Jamieson","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"11","key":"B81","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-3-11","article-title":"Recent advances in gastrointestinal oncology\u2013updates and insights from the 2009 annual meeting of the American society of clinical oncology.","volume":"3","author":"Javle","year":"2010","journal-title":"J. Hematol. Oncol."},{"issue":"e60733","key":"B82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060733","article-title":"Spinal astrocytic activation contributes to mechanical allodynia in a rat chemotherapy-induced neuropathic pain model.","volume":"8","author":"Ji","year":"2013","journal-title":"PLoS ONE"},{"key":"B83","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neulet.2006.06.043","article-title":"Sensory neurons and their supporting cells located in the trigeminal, thoracic and lumbar ganglia differentially express markers of injury following intravenous administration of paclitaxel in the rat.","volume":"405","author":"Jimenez-Andrade","year":"2006","journal-title":"Neurosci. Lett."},{"key":"B84","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1200\/JCO.2005.02.027","article-title":"Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer.","volume":"23","author":"Jones","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11060-014-1632-x","article-title":"Chemotherapy-induced peripheral neuropathies in hematological malignancies.","volume":"121","author":"Jongen","year":"2015","journal-title":"J. Neurooncol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"730","DOI":"10.2174\/156800907783220417","article-title":"How do microtubule-targeted drugs work? An overview.","volume":"7","author":"Jordan","year":"2007","journal-title":"Curr. Cancer Drug Targets"},{"key":"B87","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs.","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"B88","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/j.pain.0000000000000743","article-title":"Clinical assessment of new antineuropathic strategies for chemotherapy-induced peripheral neuropathy: pain should not be the principal endpoint.","volume":"158","author":"Kerckhove","year":"2017","journal-title":"Pain"},{"key":"B89","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/tpj.2009.45","article-title":"Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients.","volume":"10","author":"Khrunin","year":"2010","journal-title":"Pharmacogenomics J."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s11136-010-9670-0","article-title":"Chemotherapy-related polyneuropathy may deteriorate quality of life in patients with B-cell lymphoma.","volume":"19","author":"Kim","year":"2010","journal-title":"Qual. Life Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00280-015-2724-9","article-title":"Pharmacokinetically based dosing of weekly paclitaxel to reduce drug-related neurotoxicity based on a single sample strategy.","volume":"75","author":"Kraff","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3892\/ol.2013.1467","article-title":"Polymorphisms of GSTP1, ERCC2 and TS-3\u2019UTR are associated with the clinical outcome of mFOLFOX6 in colorectal cancer patients.","volume":"6","author":"Kumamoto","year":"2013","journal-title":"Oncol. Lett."},{"key":"B93","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1158\/0008-5472.CAN-04-3684","article-title":"Mitochondrial-mediated disregulation of Ca2+ is a critical determinant of Velcade (PS-341\/bortezomib) cytotoxicity in myeloma cell lines.","volume":"65","author":"Landowski","year":"2005","journal-title":"Cancer Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.neuro.2013.05.008","article-title":"Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy.","volume":"37","author":"LaPointe","year":"2013","journal-title":"Neurotoxicology"},{"key":"B95","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/jns.12114","article-title":"Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.","volume":"20","author":"Lavoie Smith","year":"2015","journal-title":"J. Peripher. Nerv. Syst."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1002\/cncr.29914","article-title":"Is it my cancer or am I just getting older?: impact of cancer on age-related health conditions of older cancer survivors.","volume":"122","author":"Leach","year":"2016","journal-title":"Cancer"},{"key":"B97","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.bbi.2006.10.012","article-title":"Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats.","volume":"21","author":"Ledeboer","year":"2007","journal-title":"Brain. Behav. Immun."},{"key":"B98","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/tpj.2010.13","article-title":"Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity.","volume":"11","author":"Leskel\u00e4","year":"2011","journal-title":"Pharmacogenomics J."},{"key":"B99","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s12185-009-0409-z","article-title":"Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2\/0 myeloma cells through affecting NFkappaB p65.","volume":"90","author":"Li","year":"2009","journal-title":"Int. J. Hematol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"13487","DOI":"10.1523\/JNEUROSCI.1956-15.2015","article-title":"The cancer chemotherapeutic paclitaxel increases human and rodent sensory neuron responses to TRPV1 by activation of TLR4.","volume":"35","author":"Li","year":"2015","journal-title":"J. Neurosci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jpain.2014.04.001","article-title":"Toll-like receptor 4 signaling contributes to Paclitaxel-induced peripheral neuropathy.","volume":"15","author":"Li","year":"2014","journal-title":"J. Pain"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.leukres.2013.09.018","article-title":"Quality of life following completion of treatment for adult acute lymphoblastic leukemia with a pediatric-based protocol.","volume":"37","author":"Liew","year":"2013","journal-title":"Leuk. Res."},{"key":"B103","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1517\/13543776.2014.859247","article-title":"Tubulin inhibitors: a patent review.","volume":"24","author":"Liu","year":"2014","journal-title":"Expert Opin. Ther. Pat."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.celrep.2015.04.027","article-title":"The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia.","volume":"11","author":"Lolignier","year":"2015","journal-title":"Cell Rep."},{"key":"B105","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/S0145-2126(12)70007-3","article-title":"How to maintain patients on long-term therapy: understanding the profile and kinetics of adverse events.","volume":"36(Suppl. 1)","author":"Mateos","year":"2012","journal-title":"Leuk. Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1158\/1535-7163.MCT-08-0840","article-title":"Platinum neurotoxicity pharmacogenetics.","volume":"8","author":"McWhinney","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"e0123866","key":"B107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123866","article-title":"Subcutaneous bortezomib in multiple myeloma patients induces similar therapeutic response rates as intravenous application but it does not reduce the incidence of peripheral neuropathy.","volume":"10","author":"Minarik","year":"2015","journal-title":"PLoS ONE"},{"key":"B108","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3324\/haematol.2009.012674","article-title":"Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations.","volume":"95","author":"Mohty","year":"2010","journal-title":"Haematologica"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1200\/JCO.2013.49.1514","article-title":"Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry.","volume":"31","author":"Mols","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/hon.2149","article-title":"Therapy-related peripheral neuropathy in multiple myeloma patients.","volume":"33","author":"Morawska","year":"2015","journal-title":"Hematol. Oncol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"5752","DOI":"10.1182\/blood-2011-05-355081","article-title":"Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma.","volume":"118","author":"Moreau","year":"2011a","journal-title":"Blood"},{"key":"B112","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S1470-2045(11)70081-X","article-title":"Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.","volume":"12","author":"Moreau","year":"2011b","journal-title":"Lancet Oncol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1439-0507.2011.02158.x","article-title":"Adverse interactions between antifungal azoles and vincristine: review and analysis of cases.","volume":"55","author":"Moriyama","year":"2012","journal-title":"Mycoses"},{"key":"B114","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3816\/CLM.2005.n.038","article-title":"Late non-neoplastic events in patients with aggressive non-Hodgkin\u2019s lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials.","volume":"6","author":"Moser","year":"2005","journal-title":"Clin. Lymphoma Myeloma"},{"key":"B115","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1046\/j.1365-2141.2001.03126.x","article-title":"Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity.","volume":"115","author":"Naumann","year":"2001","journal-title":"Br. J. Haematol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.apmr.2013.03.009","article-title":"Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: results from the St. Jude Lifetime Cohort Study.","volume":"94","author":"Ness","year":"2013","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"B117","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/MPH.0b013e31816624a4","article-title":"Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.","volume":"30","author":"Nishikawa","year":"2008","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s00277-014-2099-8","article-title":"Health-related quality of life and persistent symptoms in relation to (R-)CHOP14, (R-)CHOP21, and other therapies among patients with diffuse large B-cell lymphoma: results of the population-based PHAROS-registry.","volume":"93","author":"Oerlemans","year":"2014","journal-title":"Ann. Hematol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"229","DOI":"10.7547\/87507315-93-3-229","article-title":"Charcot-Marie-Tooth disease and vincristine.","volume":"93","author":"Orejana-Garc\u00eda","year":"2003","journal-title":"J. Am. Podiatr. Med. Assoc."},{"key":"B120","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1634\/theoncologist.2010-0248","article-title":"Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility.","volume":"16","author":"Park","year":"2011","journal-title":"Oncologist"},{"key":"B121","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00280-013-2194-x","article-title":"Association between GSTP1 Ile105Val polymorphism and oxaliplatin-induced neuropathy: a systematic review and meta-analysis.","volume":"72","author":"Peng","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.expneurol.2006.07.022","article-title":"Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells.","volume":"203","author":"Peters","year":"2007","journal-title":"Exp. Neurol."},{"issue":"5","key":"B123","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-5","article-title":"Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study.","volume":"6","author":"Pignata","year":"2006","journal-title":"BMC Cancer"},{"issue":"913848","key":"B124","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/913848","article-title":"Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer.","volume":"2012","author":"Pike","year":"2012","journal-title":"Chemother. Res. Pract."},{"key":"B125","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1212\/01.wnl.0000267271.18475.fe","article-title":"Neuropathy in multiple myeloma treated with thalidomide: a prospective study.","volume":"69","author":"Plasmati","year":"2007","journal-title":"Neurology"},{"key":"B126","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.nbd.2010.11.017","article-title":"Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons.","volume":"41","author":"Podratz","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"B127","doi-asserted-by":"publisher","first-page":"940","DOI":"10.4161\/cc.7.7.5625","article-title":"Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: a possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibition.","volume":"7","author":"Poruchynsky","year":"2008","journal-title":"Cell Cycle"},{"key":"B128","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF01050259","article-title":"Long-term effects of vincristine on the peripheral nervous system.","volume":"15","author":"Postma","year":"1993","journal-title":"J. Neurooncol."},{"issue":"e51526","key":"B129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051526","article-title":"Combination of taxanes, cisplatin and fluorouracil as induction chemotherapy for locally advanced head and neck cancer: a meta-analysis.","volume":"7","author":"Qin","year":"2012","journal-title":"PLoS ONE"},{"key":"B130","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/PL00007853","article-title":"Chemotherapy-induced peripheral neuropathy.","volume":"249","author":"Quasthoff","year":"2002","journal-title":"J. Neurol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1529-8027.2009.00230.x","article-title":"Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia.","volume":"14","author":"Ramchandren","year":"2009","journal-title":"J. Peripher. Nerv. Syst."},{"key":"B132","first-page":"128","article-title":"Bortezomib-induced polyneuropathy.","volume":"71","author":"Rampen","year":"2013","journal-title":"Neth. J. Med."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.jpain.2009.04.006","article-title":"Chemotherapy-induced peripheral neuropathy as a predictor of neuropathic pain in breast cancer patients previously treated with paclitaxel.","volume":"10","author":"Reyes-Gibby","year":"2009","journal-title":"J. Pain"},{"key":"B134","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0753-3322(02)00168-3","article-title":"Thalidomide in multiple myeloma.","volume":"56","author":"Richardson","year":"2002","journal-title":"Biomed. Pharmacother."},{"key":"B135","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1056\/NEJMoa030288","article-title":"A phase 2 study of bortezomib in relapsed, refractory myeloma.","volume":"348","author":"Richardson","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B136","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.6004\/jnccn.2010.0115","article-title":"Complications of multiple myeloma therapy, part 1: risk reduction and management of peripheral neuropathy and asthenia.","volume":"8 (Suppl. 1)","author":"Richardson","year":"2010","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"B137","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMoa043445","article-title":"Bortezomib or high-dose dexamethasone for relapsed multiple myeloma.","volume":"352","author":"Richardson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B138","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1365-2141.2008.07573.x","article-title":"Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline.","volume":"144","author":"Richardson","year":"2009","journal-title":"Br. J. Haematol."},{"key":"B139","first-page":"107","article-title":"Neurotoxicity of Taxol.","volume":"15","author":"Rowinsky","year":"1993","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"B140","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1517\/14656566.9.15.2603","article-title":"Paclitaxel and docetaxel in the treatment of breast cancer.","volume":"9","author":"Saloustros","year":"2008","journal-title":"Expert Opin. Pharmacother."},{"key":"B141","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.1158\/1078-0432.CCR-15-0586","article-title":"Genome-wide association studies for taxane-induced peripheral neuropathy in ECOG-5103 and ECOG-1199.","volume":"21","author":"Schneider","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"B142","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1200\/JCO.2011.39.8446","article-title":"Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer.","volume":"30","author":"Schneider","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.etp.2015.02.003","article-title":"Evaluation of multi-neuroprotective effects of erythropoietin using cisplatin induced peripheral neurotoxicity model.","volume":"67","author":"Sharawy","year":"2015","journal-title":"Exp. Toxicol. Pathol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1007\/s00520-012-1492-x","article-title":"Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial.","volume":"20","author":"Shimozuma","year":"2012","journal-title":"Support. Care Cancer"},{"key":"B145","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00520-015-2807-5","article-title":"Can pregabalin prevent paclitaxel-associated neuropathy?\u2013An ACCRU pilot trial.","volume":"24","author":"Shinde","year":"2016","journal-title":"Support. Care Cancer"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1213\/01.ane.0000204318.35194.ed","article-title":"Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy.","volume":"102","author":"Siau","year":"2006","journal-title":"Anesth. Analg."},{"key":"B147","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1158\/1078-0432.CCR-07-4230","article-title":"ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel.","volume":"14","author":"Sissung","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B148","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1016\/j.ejca.2006.06.017","article-title":"Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia.","volume":"42","author":"Sissung","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"B149","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neuro.2013.09.001","article-title":"Bortezomib alters microtubule polymerization and axonal transport in rat dorsal root ganglion neurons.","volume":"39","author":"Staff","year":"2013","journal-title":"Neurotoxicology"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1080\/0284186X.2016.1197420","article-title":"Oxaliplatin added to fluoropyrimidine for adjuvant treatment of colorectal cancer is associated with long-term impairment of peripheral nerve sensory function and quality of life.","volume":"55","author":"Stefansson","year":"2016","journal-title":"Acta Oncol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/annonc\/mdf058","article-title":"Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer.","volume":"13","author":"Strumberg","year":"2002","journal-title":"Ann. Oncol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tips.2004.10.002","article-title":"Bad news from the brain: descending 5-HT pathways that control spinal pain processing.","volume":"25","author":"Suzuki","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/ajh.23835","article-title":"Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study.","volume":"89","author":"Tacchetti","year":"2014","journal-title":"Am. J. Hematol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s10147-011-0352-x","article-title":"Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer.","volume":"18","author":"Tanabe","year":"2013","journal-title":"Int. J. Clin. Oncol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0031-6989(86)90147-5","article-title":"Action of vinca alkaloides on calcium movements through mitochondrial membrane.","volume":"18","author":"Tari","year":"1986","journal-title":"Pharmacol. Res. Commun."},{"key":"B156","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1188\/08.CJON.S1.29-35","article-title":"Peripheral neuropathy associated with novel therapies in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board.","volume":"12","author":"Tariman","year":"2008","journal-title":"Clin. J. Oncol. Nurs."},{"key":"B157","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/jns.12110","article-title":"Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: a genome-wide study replication and meta-analysis.","volume":"20","author":"Terrazzino","year":"2015","journal-title":"J. Peripher. Nerv. Syst."},{"key":"B158","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1007\/s12031-013-0095-4","article-title":"Structural and molecular alterations of primary afferent fibres in the spinal dorsal horn in vincristine-induced neuropathy in rat.","volume":"51","author":"Thibault","year":"2013","journal-title":"J. Mol. Neurosci."},{"key":"B159","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/cncr.23589","article-title":"Delayed emotional recovery after taxane-based chemotherapy.","volume":"113","author":"Thornton","year":"2008","journal-title":"Cancer"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1089\/jpm.2010.0124","article-title":"Surviving chemotherapy for colon cancer and living with the consequences.","volume":"13","author":"Tofthagen","year":"2010","journal-title":"J. Palliat. Med."},{"key":"B161","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1007\/s00520-013-1905-5","article-title":"Oxaliplatin-induced peripheral neuropathy\u2019s effects on health-related quality of life of colorectal cancer survivors.","volume":"21","author":"Tofthagen","year":"2013","journal-title":"Support. Care Cancer"},{"key":"B162","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neuro.2006.07.005","article-title":"Cisplatin modulates voltage gated channel currents of dorsal root ganglion neurons of rats.","volume":"28","author":"Tomaszewski","year":"2007","journal-title":"Neurotoxicology"},{"key":"B163","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.clpt.2006.02.003","article-title":"Pharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphisms.","volume":"79","author":"Tran","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/0959-8049(94)90459-6","article-title":"Paclitaxel (Taxol) induces cumulative mild neurotoxicity.","volume":"30A","author":"van Gerven","year":"1994","journal-title":"Eur. J. Cancer"},{"key":"B165","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00520-013-2004-3","article-title":"A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer.","volume":"22","author":"Vatandoust","year":"2014","journal-title":"Support. Care Cancer"},{"key":"B166","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1529-8027.2010.00248.x","article-title":"Neurological monitoring reduces the incidence of bortezomib-induced peripheral neuropathy in multiple myeloma patients.","volume":"15","author":"Velasco","year":"2010","journal-title":"J. Peripher. Nerv. Syst."},{"key":"B167","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/j.pain.0000000000000404","article-title":"Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel.","volume":"157","author":"Ventzel","year":"2016","journal-title":"Pain"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1212\/01.WNL.0000154642.45474.28","article-title":"Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening.","volume":"64","author":"Verstappen","year":"2005","journal-title":"Neurology"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00520-012-1667-5","article-title":"Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV.","volume":"21","author":"Vincenzi","year":"2013","journal-title":"Support. Care Cancer"},{"key":"B170","doi-asserted-by":"publisher","first-page":"R811","DOI":"10.1152\/ajpregu.00543.2007","article-title":"Cyclosporine increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system.","volume":"294","author":"Wang","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/CAD.0000000000000063","article-title":"Nature as a remarkable chemist: a personal story of the discovery and development of Taxol.","volume":"25","author":"Wani","year":"2014","journal-title":"Anticancer Drugs"},{"key":"B172","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1365-2796.2004.01443.x","article-title":"Immune regulation of central nervous system functions: from sickness responses to pathological pain.","volume":"257","author":"Watkins","year":"2005","journal-title":"J. Intern. Med."},{"key":"B173","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.pain.2011.12.011","article-title":"Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin.","volume":"153","author":"Xiao","year":"2012","journal-title":"Pain"},{"issue":"69","key":"B174","doi-asserted-by":"publisher","DOI":"10.1186\/s12990-015-0072-8","article-title":"Transient receptor potential ankyrin 1 that is induced in dorsal root ganglion neurons contributes to acute cold hypersensitivity after oxaliplatin administration.","volume":"11","author":"Yamamoto","year":"2015","journal-title":"Mol. Pain"},{"issue":"e89583","key":"B175","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089583","article-title":"Spinal changes of a newly isolated neuropeptide endomorphin-2 concomitant with vincristine-induced allodynia.","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS ONE"},{"key":"B176","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1200\/JCO.2011.36.4539","article-title":"Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses.","volume":"29","author":"Yothers","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.clcc.2013.11.004","article-title":"Oxaliplatin-induced neuropathy in colorectal cancer: many questions with few answers.","volume":"13","author":"Zedan","year":"2014","journal-title":"Clin. Colorectal Cancer"},{"key":"B178","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2147\/DDDT.S56801","article-title":"Paclitaxel: new uses for an old drug.","volume":"8","author":"Zhang","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"key":"B179","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.expneurol.2012.08.023","article-title":"Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy.","volume":"238","author":"Zheng","year":"2012","journal-title":"Exp. Neurol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00086\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T21:26:06Z","timestamp":1568841966000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00086\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,24]]},"references-count":179,"URL":"https:\/\/doi.org\/10.3389\/fphar.2017.00086","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,24]]}}}